Gene: JAM2
Official Full Name: junctional adhesion molecule 2provided by HGNC
Gene Summary: This gene belongs to the immunoglobulin superfamily, and the junctional adhesion molecule (JAM) family. The protein encoded by this gene is a type I membrane protein that is localized at the tight junctions of both epithelial and endothelial cells. It acts as an adhesive ligand for interacting with a variety of immune cell types, and may play a role in lymphocyte homing to secondary lymphoid organs. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Jul 2012]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO00051 | JAM2 Knockout cell line (HCMEC/D3) | Human | JAM2 | 1:3~1:4 | Negative | Online Inquiry |
KO01266 | JAM2 Knockout cell line (MDCK) | Dog | JAM2 | Negative | Online Inquiry | |
KO06942 | JAM2 Knockout cell line (HEK293) | Human | JAM2 | 1:3~1:6 | Negative | Online Inquiry |
JAM2 Gene Knockout Cell Lines are specialized cellular models engineered to lack the Junctional Adhesion Molecule 2 (JAM2) gene, a pivotal player in various cell signaling pathways and immune responses. These cell lines are crucial for studying the role of JAM2 in cell adhesion, migration, and immune cell interactions, which are essential processes in both normal physiology and the pathogenesis of various diseases, including cancer and autoimmune disorders. By utilizing CRISPR-Cas9 technology, these knockout cell lines effectively disrupt JAM2 expression, providing a robust platform for functional assays that investigate cellular behaviors under JAM2-deficient conditions.
The key functions of JAM2 encompass its involvement in tight junction formation and immune responses, facilitating proper cell-to-cell adhesion and signaling. By elucidating the mechanisms by which the absence of JAM2 influences cellular dynamics, researchers can gain valuable insights into cell migration patterns, permeability, and immune system modulation. In clinical settings, understanding these processes can directly impact therapeutic strategies, particularly in designing novel treatments that target cell adhesion pathways.
Among the primary advantages of the JAM2 Gene Knockout Cell Lines are their precise genetic alterations and the ease with which they can be utilized in various experimental setups. Unlike conventional cell lines, these knockout models provide a clearer understanding of JAM2-related functions without confounding effects from endogenous JAM2 expression. They are ideal for drug testing, biomarker discovery, and pathway analysis, offering researchers a unique opportunity to develop targeted therapies with greater efficacy.
These cell lines are an invaluable asset for scientists and clinicians who are investigating the complexities of cell adhesion and immune interactions. By employing JAM2 Gene Knockout Cell Lines in their research, users can contribute to the progression of understanding how targeted modulation of cell signaling pathways can influence disease outcomes.
Our company specializes in the development and production of high-quality genetic models, with an unwavering commitment to advancing research in cellular biology. With our expertise, we provide reliable and innovative solutions that empower researchers and clinicians alike, enabling them to make significant strides in their scientific endeavors.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.